Israel Englander Alx Oncology Holdings Inc Call Options Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$5.84 - $17.56 $584,000 - $1.76 Million
100,000 Added 333.33%
130,000 $783,000
Q1 2024

May 15, 2024
SELL
$10.95 - $16.79 $127,019 - $194,764
-11,600 Reduced 27.88%
30,000 $334,000
Q4 2023

Feb 14, 2024
SELL
$4.81 - $15.38 $42,809 - $136,882
-8,900 Reduced 17.62%
41,600 $619,000
Q2 2023

Aug 14, 2023
BUY
$4.37 - $9.56 $220,685 - $482,780
50,500 New
50,500 $379,000

Others Institutions Holding ALXO

# of Institutions
101
Shares Held
39.7M
Call Options Held
134K
Put Options Held
17.4K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $54.2M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email